Literature DB >> 7905238

Inhibitory effect of coumarins on HIV-1 replication and cell-mediated or cell-free viral transmission.

A S Bourinbaiar1, X Tan, R Nagorny.   

Abstract

A single dose of coumarin derivatives, warfarin, 4-hydroxycoumarin and umbelliferone, added at the time of inoculation either by free virus or by contact with U1 monocytes exhibited a dose-dependent inhibitory effect on viral replication in target MOLT-4 lymphocytes observable even at 5 days post infection. In addition, marked decrease of HIV-1 gap p24 release and reduction in reverse transcriptase activity was observed when chronically HIV-infected ACH-2 lymphocytes were treated with coumarins (ED50% range 10(-6)-10(-9) mol/l). However, the intracellular composition of HIV-1 core proteins in drug-exposed cells was not modified. Results suggest that although no complete inhibition of viral production has been observed in vitro this class of drugs may present potential interest as antiviral agents.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7905238

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  4 in total

1.  Microwave-induced synthesis of schiff bases of aminothiazolyl bromocoumarins as antibacterials.

Authors:  K N Venugopala; B S Jayashree
Journal:  Indian J Pharm Sci       Date:  2008-01       Impact factor: 0.975

2.  Structure-Activity Relationships of Synthetic Coumarins as HIV-1 Inhibitors.

Authors:  I Kostova; S Raleva; P Genova; R Argirova
Journal:  Bioinorg Chem Appl       Date:  2006-02-23       Impact factor: 7.778

3.  Comparison of various techniques for the extraction of umbelliferone and herniarin in Matricaria chamomilla processing fractions.

Authors:  Maja Molnar; Nikolina Mendešević; Drago Šubarić; Ines Banjari; Stela Jokić
Journal:  Chem Cent J       Date:  2017-08-05       Impact factor: 4.215

4.  Inhibitory effect of the oral immune response modifier, bestatin, on cell-mediated and cell-free HIV infection in vitro.

Authors:  A S Bourinbaiar; S Lee-Huang; K Krasinski; W Borkowsky
Journal:  Biomed Pharmacother       Date:  1994       Impact factor: 6.529

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.